Donald Ellis analyst

Currently out of the existing stock ratings of Donald Ellis, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).

Donald Ellis

Work Performance Price Targets & Ratings Chart

Analyst Donald Ellis, has had 57.42% of price targets met with an average potential upside of 60.1%, reached in 532 days on average. Previously, Donald Ellis worked at JMP.

Donald Ellis has documented 75 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on CLS, Celestica at 21-Dec-2021.

Wall Street Analyst Donald Ellis

Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) on 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%), with a performance score of 15.25.

Average potential price target upside

ACRS Aclaris Therapeutics AERI Aerie Pharmaceuticals ENDP Endo International PLC HZNP Horizon Pharma PLC CLSD Clearside Biomedical OCUL Ocular Therapeutix PCRX Pacira Pharmaceuticals SLGL Sol Gel Technologies Ltd EOLS Evolus CLS Celestica MNLO Menlo Therapeutics PLXP PLx Pharma

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-May-2025

$3

$-0.61 (-16.90%)

$8

3 days ago
(16-Nov-2026)

Buy Since 13-May-2025

$16

$12.39 (343.21%)

$16

23 days ago
(27-Oct-2026)

0/11 (0%)

$12.21 (322.16%)

Hold Since 05-Nov-2024

$4

$0.39 (10.80%)

$3

6 months 12 days ago
(07-May-2026)

4/5 (80%)

$-0.93 (-18.86%)

50

Buy Since 04-May-2026

$11

$7.39 (204.71%)

$6

6 months 15 days ago
(04-May-2026)

1/2 (50%)

$6.25 (131.58%)

391

Buy Since 28-Nov-2016

$12

$8.39 (232.41%)

6 months 15 days ago
(04-May-2026)

0/2 (0%)

$7.25 (152.63%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?